Progress on new vaccine strategies against chronic viral infections - Wikidata - awgldk - TriplyDB

Progress on new vaccine strategies against chronic viral infections

Progress on new vaccine strategies against chronic viral infections

http://www.wikidata.org/entity/Q35864857

about

Modulation of antigen-specific T-cells as immune therapy for chronic infectious diseases and cancer Viral Vaccines and CTL Response Engineering antigen-specific T cells from genetically modified human hematopoietic stem cells in immunodeficient mice.Interference of retroviral envelope with vaccine-induced CD8+ T cell responses is relieved by co-administration of cytokine-encoding vectors.Adjuvant IL-7 or IL-15 overcomes immunodominance and improves survival of the CD8+ memory cell pool.A conformation-dependent neutralizing monoclonal antibody specifically targeting receptor-binding domain in Middle East respiratory syndrome coronavirus spike protein.Characterization of the specific CD4+ T cell response against the F protein during chronic hepatitis C virus infection Increased immunogenicity of HIV-1 p24 and gp120 following immunization with gp120/p24 fusion protein vaccine expressing alpha-gal epitopes A conserved E7-derived cytotoxic T lymphocyte epitope expressed on human papillomavirus 16-transformed HLA-A2+ epithelial cancers.Strategies to use immune modulators in therapeutic vaccines against cancer Immunization delivered by lentiviral vectors for cancer and infectious diseases.Construction and characterization of chimeric BHIV (BIV/HIV-1) viruses carrying the bovine immunodeficiency virus gag gene.Protective capacity of memory CD8+ T cells is dictated by antigen exposure history and nature of the infection Phytol-based novel adjuvants in vaccine formulation: 2. Assessment of efficacy in the induction of protective immune responses to lethal bacterial infections in mice.Possible therapeutic vaccine strategy against human immunodeficiency virus escape from reverse transcriptase inhibitors studied in HLA-A2 transgenic mice Non-equilibrium and differential function between intraepithelial and lamina propria virus-specific TCRalphabeta(+) CD8alphabeta(+) T cells in the small intestinal mucosa.Vaccination of cats with attenuated feline immunodeficiency virus proviral DNA vaccine expressing gamma interferon Inhibition of indoleamine 2,3-dioxygenase (IDO) enhances elimination of virus-infected macrophages in an animal model of HIV-1 encephalitis Impact of vaccine-induced mucosal high-avidity CD8+ CTLs in delay of AIDS viral dissemination from mucosa.The role of models in understanding CD8+ T-cell memory.Antibody-recruiting molecules: an emerging paradigm for engaging immune function in treating human disease.HIV-1(89.6) Gag expressed from a replication competent HSV-1 vector elicits persistent cellular immune responses in mice Intensified and protective CD4+ T cell immunity in mice with anti-dendritic cell HIV gag fusion antibody vaccine Adenovirus as vehicle for anticancer genetic immunotherapy.Optimal blood mononuclear cell isolation procedures for gamma interferon enzyme-linked immunospot testing of healthy Swedish and Tanzanian subjects.Delivery systems and adjuvants for oral vaccines.Generation of functionally active HIV-1 specific CD8+ CTL in intestinal mucosa following mucosal, systemic or mixed prime-boost immunization.Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets A new era in HIV vaccine development.Chimeric HBcAg virus-like particles presenting a HPV 16 E7 epitope significantly suppressed tumor progression through preventive or therapeutic immunization in a TC-1-grafted mouse model.Vaccination sequence effects on immunological response and tissue bacterial burden in paratuberculosis infection in a rabbit model.Bloodborne viral hepatitis infections among drug users: the role of vaccination Strategies for optimizing targeting and delivery of mucosal HIV vaccines.Fabrication of nanoadjuvant with poly-ε-caprolactone (PCL) for developing a single-shot vaccine providing prolonged immunity.Enhancing immunogenicity and cross-reactivity of HIV-1 antigens by in vivo targeting to dendritic cells.Past speculations of future health technologies: a description of technologies predicted in 15 forecasting studies published between 1986 and 2010.Immune deficiency in HIV-1 infection: novel therapeutic approaches targeting innate and adaptive responses.Increased immunogenicity of human immunodeficiency virus gp120 engineered to express Galalpha1-3Galbeta1-4GlcNAc-R epitopes.Fms-like tyrosine kinase 3 receptor ligand (Flt3L)-based vaccination administered with an adenoviral vector prevents tumor growth of colorectal cancer in a BALB/c mouse model.Could therapeutic vaccination of cytomegalovirus-seropositive persons prevent reinfection and congenital virus transmission?

P2860

Q27022761-08D08E68-5B60-4F50-8DDC-D6B0D7985D4C Q27491330-2A9E8C5F-61FC-46A1-BF57-7277304D75A8 Q30974719-BB65B524-01D4-4478-9D10-29FD55476893 Q33613835-7728E461-A347-4CB0-AF7B-A6B901C4C29A Q33736534-9401F1C7-69C2-4EFC-A4FB-21C265981C8B Q33743790-4140CD34-8846-4164-BC9C-440B723F13FF Q33769438-A049CA26-A373-4DCF-9AD7-7F9884A0C890 Q33837215-DA7AC49B-794F-4CC3-ABC1-7DA5B6BF782B Q34121681-220F3075-DC4F-4047-B0F9-71786E06FBD7 Q34275601-1AFDA817-566E-4E75-8E14-7D0E2B2E21C6 Q34539879-3CCB5412-0225-4EA9-904D-29D15DA69D7D Q35010631-8E95538F-3043-4BDA-9E4A-240CAA41789D Q35012041-0E1FE53C-B376-4645-892B-D1F1641A295F Q35125351-2BBACAD9-9E2A-47A0-99C3-161C2DAC0E6C Q35139305-A8F03733-55E3-41C1-BCF5-8EC6E86D71AD Q35575565-915525E8-64F3-40FA-AA96-31B09C3FAD84 Q35634943-0CAA00E9-395C-4BAE-A2BB-44C1DC603CAA Q35848218-622B841B-50DB-48CE-82C2-8564F13C5888 Q35849596-768C5072-1FB5-412B-866E-82C5A00686C0 Q36015867-49C0B4C8-B84B-4908-9BA0-18E396C7CDD2 Q36108119-B076358A-FCFA-4357-8902-1770A9ED4D83 Q36156347-5853DF71-8DED-433C-A392-EE1612F9947C Q36228405-1888A522-1336-4441-A29B-DED5A7FC4E30 Q36288930-36448558-5266-481E-9C8E-66AB4AEEC82A Q36539081-FE879C44-1D05-4EBD-8AE5-653B462C14B2 Q36640326-D695CE0C-11B0-4E82-B23E-A001C45A2CAE Q36663607-B8924AEA-044E-4A35-A1F1-4394DFA9174E Q36742299-64079455-E140-482D-8333-2423ED911748 Q36777835-A843298F-108E-4B2B-8A7A-9DB135A37900 Q36967911-85AD6BE4-9D4A-43CF-ABA6-896EF676C41A Q37156509-5FB84DB7-AC7B-46F3-A242-8C5E63F5BFBC Q37167103-492F3220-0096-4DE9-AD70-D8CBDB503015 Q37554135-3303E219-B0FA-4FDB-A71E-8DF0A6A255D0 Q37591932-3B6A2B5B-85A5-4EB1-BB0C-65379FEE3DB2 Q38059499-24FF155E-0BCA-453E-93EA-A0DE98C92223 Q38649073-0C80AE2E-1D35-4B42-8840-8D60C173F4FC Q40377124-D9A03EBA-AD6E-4F69-960B-F178BA082D97 Q41495119-D81F013B-56FE-43E5-BC1A-BAC8998A2F88 Q42263453-7DCFBDB0-5633-446A-9425-35810E8DECED Q42735574-D28B0511-FA30-4914-86A0-A5693E86A49E

P2860

Progress on new vaccine strategies against chronic viral infections

http://www.wikidata.org/entity/Q35864857

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Progress on new vaccine strategies against chronic viral infections

@ast

Progress on new vaccine strategies against chronic viral infections

@en

type

label

Progress on new vaccine strategies against chronic viral infections

@ast

Progress on new vaccine strategies against chronic viral infections

@en

prefLabel

Progress on new vaccine strategies against chronic viral infections

@ast

Progress on new vaccine strategies against chronic viral infections

@en

P1433

Q35864857-A3395592-7FBE-4ACC-B827-BE923D953A97

P1476

Q35864857-C0570D8C-B516-4CA0-816C-E36BF8A0229F

P2093

Q35864857-071F1828-DBB4-433D-884B-917866E00B23

Q35864857-0C69C38B-0022-4799-9ED3-F244AABB8563

Q35864857-0F821088-276F-40C4-A956-8808FA4F943F

Q35864857-4C8122D5-6815-443C-8672-186E90BBC100

Q35864857-6437DAB6-1A17-42A7-A35B-22FD32CDD8EF

Q35864857-DBA49B3E-430C-43FB-8B74-4DF160E49BE8

Q35864857-FEDE113E-502A-431B-8F0D-74A23441FC15

P2860

Q35864857-01067AA9-06A6-44ED-97F0-84A8D03E91C1

Q35864857-02532728-9243-4FDC-A379-947DCEDAEA78

Q35864857-0A6D4EE1-9E0D-43A5-BC03-41B1A23B138D

Q35864857-0BBA7835-CFA4-4E52-B1AC-67D591BE9688

Q35864857-0DCC429A-F8B7-4204-AE80-D0634BB64D28

Q35864857-113938ED-C8AF-4F7B-9F35-CD3316800606

Q35864857-114A39DF-E1F6-438C-9061-9AEE62C06624

Q35864857-120B4CEF-4E47-4F18-A177-48B108F1E70B

Q35864857-121C7A93-1A75-4D46-BFEE-633B9EDD5165

Q35864857-126D1FE5-E8E9-49DC-8003-622A0E2912BA

P304

Q35864857-7D9B4BD4-69CF-4C04-98CA-86177F47B7D2

P31

Q35864857-B1F904AF-35D9-4692-96A0-493F35D437E1

P356

Q35864857-1F70B7F7-82C0-4E2A-99CB-6FBBA6C374B2

P407

Q35864857-A0B10BE4-03A0-4C76-BFD3-7CBA056FF906

P433

Q35864857-465ED56E-913B-45A5-8673-595540D41931

P478

Q35864857-5D79AC31-C468-43A6-9E7F-E9D3C31D0765

P577

Q35864857-9A8A668F-C1DC-4340-BF3F-4FB782382C24

P698

Q35864857-A8217BAE-832C-4A56-B4C4-10236FB1EB1A

P932

Q35864857-E00920C8-0103-484E-BB41-835E7619A9A7

P356

P1433

Journal of Clinical Investigation

P1476

Progress on new vaccine strategies against chronic viral infections

@en

P2093

Igor M Belyakov

http://www.w3.org/2001/XMLSchema#string

Jay A Berzofsky

http://www.w3.org/2001/XMLSchema#string

Jeffrey D Ahlers

http://www.w3.org/2001/XMLSchema#string

John Janik

http://www.w3.org/2001/XMLSchema#string

John Morris

http://www.w3.org/2001/XMLSchema#string

Masaki Terabe

http://www.w3.org/2001/XMLSchema#string

SangKon Oh

http://www.w3.org/2001/XMLSchema#string

P2860

Pathogenesis of human immunodeficiency virus infection

Previously Infected and Recovered Chimpanzees Exhibit Rapid Responses That Control Hepatitis C Virus Replication upon Rechallenge

DNA immunization with hepatitis C virus (HCV) polycistronic genes or immunization by HCV DNA priming-recombinant canarypox virus boosting induces immune responses and protection from recombinant HCV-vaccinia virus infection in HLA-A2.1-transgenic mi

Kinetics of CD4+ and CD8+ Memory T-Cell Responses during Hepatitis C Virus Rechallenge of Previously Recovered Chimpanzees

Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules

Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection

Alternative conformations of HIV-1 V3 loops mimic beta hairpins in chemokines, suggesting a mechanism for coreceptor selectivity

Determinants of viral clearance and persistence during acute hepatitis C virus infection

Two subsets of memory T lymphocytes with distinct homing potentials and effector functions

Lineage relationship and protective immunity of memory CD8 T cell subsets

P304

450-462

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI200422674

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

114

http://www.w3.org/2001/XMLSchema#string

P577

2004-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15314679

http://www.w3.org/2001/XMLSchema#string

P932

503779

http://www.w3.org/2001/XMLSchema#string